Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

La Jolla Pharmaceutical Co (NASDAQ:LJPC)

29.06
Delayed Data
As of Jun 21
 +0.96 / +3.42%
Today’s Change
14.63
Today|||52-Week Range
39.28
+65.77%
Year-to-Date

Today’s Trading

Previous close28.10
Today’s open28.26
Day’s range28.26 - 30.29
Volume318,316
Average volume (3 months)779,067
Market cap$642.9M
Dividend yield--
Data as of 06/21/2017

Growth & Valuation

Earnings growth (last year)-69.40%
Earnings growth (this year)-7.80%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)-41.72%
P/E ratioNM
Price/Sales490.27
Price/Book9.76

Competitors

 Today’s
change
Today’s
% change
ARGXargenx NV-0.11-0.53%
NUTRNutraceutical Intern...0.000.00%
NATRNatures Sunshine Pro...+0.50+3.85%
NVLNNovelion Therapeutic...-0.09-0.90%
Data as of 06/21/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$1.18
Annual revenue (last year)$616.0K
Annual profit (last year)-$78.2M
Net profit margin-12,692.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
George Francis Tidmarsh
Senior Vice President-
Operations
Jennifer Carver
Corporate headquarters
San Diego, California

Forecasts